Presentation Information
[H931-4am-06]Internal radioisotope therapy utilizing [3+2] cycloaddition reaction with cancer metabolites
○Yudai Ode1, Akihiro Ishiwata2, Ambara Rachmat Pradipta1, Katsunori Tanaka1,2 (1. Tokyo Institute of Technology, School of Materials and Chemical Technology, Department of Chemical Science and Engineering, 2. RIKEN Cluster for Pioneering Research, Biofunctional Synthetic Chemistry Laboratory)
Keywords:
RI internal Therapy,Cancer,Acrolein,[3+2] cycloaddition,Aryl azide